Filtros de búsqueda

Lista de obras de Anthonie J van der Wekken

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

scientific article published on 26 November 2018

A novel EGFR mutation in exon 19 showed stable disease after TKI treatment

artículo científico publicado en 2012

An instrument dedicated for modelling of pulmonary radiotherapy

artículo científico publicado en 2015

CT-guided percutaneous hookwire localization increases the efficacy and safety of VATS for pulmonary nodules

artículo científico publicado en 2017

CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor

scientific article published on 30 March 2019

Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer

artículo científico publicado en 2016

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

artículo científico publicado en 2015

Concomitant mutation status of <i>ALK</i>-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib

artículo científico publicado en 2021

Copy number alterations assessed at the single-cell level revealed mono- and polyclonal seeding patterns of distant metastasis in a small cell lung cancer patient.

artículo científico publicado en 2017

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2017

Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing

artículo científico publicado en 2016

Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?

scientific article published on 01 July 2018

KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC

artículo científico publicado en 2018

Moving forward with circulating tumor cells and lung cancer

artículo científico publicado en 2012

Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer

scientific article published on 20 December 2019

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

artículo científico publicado en 2017

Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature

artículo científico publicado en 2016

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification.

artículo científico publicado en 2018

The value of proteomics in lung cancer

artículo científico publicado en 2015

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda